company background image
541400 logo

ZIM Laboratories BSE:541400 Stock Report

Last Price

₹111.30

Market Cap

₹5.5b

7D

0.2%

1Y

-3.5%

Updated

26 Dec, 2024

Data

Company Financials

ZIM Laboratories Limited

BSE:541400 Stock Report

Market Cap: ₹5.5b

541400 Stock Overview

Engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. More details

541400 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Rewards

Price-To-Earnings ratio (33.6x) is below the Pharmaceuticals industry average (34.8x)

Risk Analysis

Does not have a meaningful market cap (₹5B)


My Notes

Capture your thoughts, links and company narrative

ZIM Laboratories Limited Competitors

Jenburkt Pharmaceuticals

BSE:524731

₹5.3b

Accent Microcell

NSEI:ACCENTMIC

₹5.7b

Medico Remedies

BSE:540937

₹4.4b

Kilitch Drugs (India)

BSE:524500

₹5.2b

Price History & Performance

Summary of share price highs, lows and changes for ZIM Laboratories
Historical stock prices
Current Share Price₹111.30
52 Week High₹131.30
52 Week Low₹89.90
Beta0.61
1 Month Change0.95%
3 Month Change0%
1 Year Change-3.47%
3 Year Change187.84%
5 Year Change336.76%
Change since IPO218.83%

Recent News & Updates

Recent updates

Shareholder Returns

541400IN PharmaceuticalsIN Market
7D0.2%0.2%-2.5%
1Y-3.5%38.1%17.9%

Return vs Industry: 541400 underperformed the Indian Pharmaceuticals industry which returned 38.1% over the past year.

Return vs Market: 541400 underperformed the Indian Market which returned 17.9% over the past year.

Price Volatility

Is 541400's price volatile compared to industry and market?
541400 volatility
541400 Average Weekly Movement6.0%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 541400 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 541400's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1984556Chandrashekhar Maindewww.zimlab.in

ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. The company provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. It offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements.

ZIM Laboratories Limited Fundamentals Summary

How do ZIM Laboratories's earnings and revenue compare to its market cap?
541400 fundamental statistics
Market cap₹5.50b
Earnings (TTM)₹161.50m
Revenue (TTM)₹3.88b

33.6x

P/E Ratio

1.4x

P/S Ratio

Is 541400 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
541400 income statement (TTM)
Revenue₹3.88b
Cost of Revenue₹1.89b
Gross Profit₹1.99b
Other Expenses₹1.83b
Earnings₹161.50m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)3.31
Gross Margin51.36%
Net Profit Margin4.16%
Debt/Equity Ratio40.1%

How did 541400 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 17:06
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ZIM Laboratories Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution